Meridian Medical Technologies, a unit of CDMO Kindeva, snared a $129 million contract to supply the United States with the chemical nerve agent antidote autoinjector DuoDote. The FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback